Based on the extensive tools in molecular genetics and instruments available at RIKEN Yokohama and on long-standing experience with the incorporation of unnatural amino acids in proteins such as antibodies, RIKEN will employ several teams headed by senior researchers...
The team of Professor Osamu NUREKI at the University of Tokyo crystallized a “multidrug and toxic compound extrusion exporter” protein (MATE) within a lipid and solved its x-ray structure. The membrane protein is v-shaped and in the presence of a drug changes...
After a ringtest comprising 12 Japanese organizations, flakes of ground beef, dried soybeans and mushrooms will be distributed as reference material, to be followed by brown rice. The program is in cooperation with JST. Nikkei Biotech, March 28, 2013
Retina Institute Japan, Fukuoka, develops an iPS-based cure for age-related macular degeneration. The IP is on exclusive license from RIKEN, and Dainippon Sumitomo Pharma buys for 1.500 million Yen (12 million €) on an exclusive third party agreement. Retina Institute...
The website offers information on stem cell stocks, including huan iPS cells, and is supported by the Ministry of Health Labour and Welfare Nikkei Biotech, March 27 2013
